Purchases and Sales Made in Q3 2023 in Candel Therapeutics, Inc. (CADL)
This table provides information about the institutional ownership of Candel Therapeutics, Inc. (CADL) during Q3 2023. The information is specifically focused on institutions that hold shares of Candel Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
32.2KNew |
$29.3K - $41.8K
|
32.2K
$285K
|
|
Nov 13, 2023
Q3 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
8.05K+ 6.14% |
$7.33K - $10.5K
|
139K
$1.24M
|
|
Nov 14, 2023
Q3 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
385+ 4.66% |
$350 - $501
|
8.65K
$76.7K
|
|
Nov 14, 2023
Q3 2023
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
143+ 87.73% |
$130 - $186
|
306
$2.71K
|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
17+ 9.14% |
$15.5 - $22.1
|
203
$1.8K
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
4+ 3.85% |
$3.64 - $5.2
|
108
$958
|
|
Nov 13, 2023
Q3 2023
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
1New |
$0.91 - $1.3
|
1
$8.87
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 01, 2023
Q3 2023
|
Empirical Asset Management, LLC
|
SELL
|
- |
-1K- 9.09% |
$910 - $1.3K
|
10K
$88.7K
|
|
Nov 14, 2023
Q3 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-1.69K- 0.42% |
$1.53K - $2.19K
|
404K
$3.58M
|
|
Nov 13, 2023
Q3 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.97K- 3.81% |
$1.8K - $2.57K
|
49.8K
$442K
|
|
Oct 25, 2023
Q3 2023
|
Baystate Wealth Management LLC
|
SELL
|
- |
-3.23K- 3.21% |
$2.94K - $4.2K
|
97.3K
$863K
|